ヴィクトール・アレクサンダー・クロル医師は、デュッセルドルフのザンクト・マルティヌス病院において消化器内科および内科部門を統括し、肥満および代謝疾患の高度治療を専門としています。
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Assoc. Prof. Dr. Özlem Köroğlu is a specialist in Physical Medicine and Rehabilitation at Memorial Ankara Hospital (2024–present). She previously served as a faculty member at Gaziler Physical Therapy and Rehabilitation Training and Research Hospital (2016–2024). She was Chief of the Physical Medicine and Rehabilitation Clinic at Elazığ Military Hospital (2011–2015). She earned her MD in 2003 from the GATA Faculty of Medicine. She completed her PM&R residency in 2011.
Her credentials include Ministry of Health–approved certified prolotherapy training. She has taught Prolotherapy and PRP (2022) and Knee Prolotherapy and Campinject (2019). She also taught GETAT and Dextrose Prolotherapy (2018) and ISPRM Ultrasound (2009). She has additional training in musculoskeletal ultrasound, neural therapy, lumbar injections and manipulation, and botulinum toxin treatment for the spastic hand. She attended the Euro‑Mediterranean PRM School in Italy (2010). She is a member of the Turkish Society of PM&R, the Turkish Society for Research and Fight Against Rheumatism, the Association of PM&R Specialists of Türkiye, the Spinal Cord Diseases Association, and the Ankara Medical Chamber.
Through rigorous training and practical experience, they have developed a deep understanding of Urology, earning recognition for their diagnostic skills and effective treatment approaches. Dr. Ahmet Tevfik Albayrak is a distinguished member of the European Society for Sexual Medicine (ESSM), a testament to their expertise and dedication in the field of sexual health. As a member of the ESSM, Dr. Ahmet Tevfik Albayrak remains connected to a network of professionals dedicated to advancing the field of sexual medicine. Their contributions to research, education, and clinical practice have earned them recognition from their peers and gratitude from the patients they serve. Furthermore, through their involvement with the ESSM, Dr. Ahmet Tevfik Albayrak stays abreast of the latest developments in sexual medicine, ensuring that they are equipped with the knowledge and skills needed to provide the highest quality of care to their patients. Their commitment to excellence and their compassionate approach to patient care continue to make a meaningful impact on the field of sexual health.
マーカス・デュークス教授は、診断放射線学と低侵襲治療の専門家です。
マーカス・デュークスは、CTガイド下での肝臓および肺腫瘍の低侵襲マイクロ波焼灼を実施した最初の医師の一人です。
教授は、ライン＝マイン地域で唯一のMRIガイド下のFUS焼灼センターを主導しています。多くの場合、この手法は外科的介入を回避することができます。センターの患者は、前立腺癌、骨および肝臓の転移、良性腫瘍、および非手術による子宮筋腫の焼灼の治療を受けることができます。
Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.
Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.
Dr. David (Dudi) Mishali, MD, is Director of Pediatric and Congenital Cardiothoracic Surgery at Sheba Medical Center. He treats infants and children with congenital heart defects. His work includes rare, high-risk anomalies and complex newborn reconstructions.
He trained internationally. He completed his residency at Rabin Medical Center and clinical fellowships in cardiac surgery at the Cleveland Clinic and in congenital pediatric cardiothoracic surgery at UCSF. He is board certified in cardiothoracic surgery. He developed and implemented minimally invasive methods that reduce surgical trauma and improve cosmetic results.
He is a Senior Lecturer at Tel Aviv University’s Sackler Faculty of Medicine. He has written many peer-reviewed papers and book chapters, including on point-of-care testing in children during cardiopulmonary bypass and on accessory mitral valve tissue. He holds a leadership role at a hospital ranked among the world’s top 10.
Dr. Borja Núñez de Aysa is the Director of the Ultrasound Interventional and Biological Therapies Unit at Olympia Quirónsalud. His appointment is a major development in the field of sports medicine, promising to take the institution to a new level of quality of care.
Medical career:
Special achievements:
Dr. Nunes de Aysa and his team have created one of the most modern departments in Europe, offering innovative and highly effective treatment methods. His work not only helps athletes recover faster from injuries, but also sets new standards in medical practice, making quality treatment available to every patient.
Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.
He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.
He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.
An expert in microbial resistance and optimisation of the use of antimicrobials, he leads the Infectious Disease Unit of this hospital in Malaga.
Dr Javier Moreno Izarra is habitually involved in national and international scientific events. At the same time, he gives presentations that are specially focused on infectious disease in the area of antimicrobial resistance and in medical forums dedicated to the development of programs to optimise the use of antimicrobials.
Professional Experience:
• Head of the Internal Medicine Unit. Quirónsalud Marbella Hospital
• Head of the Internal Medicine Unit. Quirón Campo de Gibraltar Hospital
• Specialist of the Internal Medicine Unit. Alto Guadalquivir Hospital
• Specialist of the Internal Medicine Unit. Andújar Hospital
• Medical Coordination of the A&E Unit and Hospitalisation. High- resolution Hospital in Puente Genil
• Specialist of the Internal Medicine Unit. Costa del Sol Hospital
A member of:
• Spanish Society of Internal Medicine
• Spanish Society of Infectious Disease and Clinical Microbiology
• Spanish Society of Palliative Care
The Internal Medicine speciality is a branch of medicine that focuses on the diagnosis, treatment and prevention of diseases and conditions of adult patients. Internists of the Quirónsalud Marbella Hospital are experts in the comprehensive health care of their patients as they manage a broad range of medical conditions. The team of specialists of our Marbella hospital stands out for its comp rehensive approach and deep knowledge and skills relating to chronic disease. Their objective is to provide a high-quality medical service while guiding the patient and coordinating the actions against their diseases in close cooperation with the other specialists, if necessary, in order to obtain an adequate diagnosis and treatment. One fundamental part of the work of an internist is the management of chronical diseases such as diabetes, hypertension, heart and lung disease, amongst others.
These conditions often require follow-ups and adjustments to the treatment throughout time.
The Internal Medicine team does not only focus on the treatment of diseases, but also on their prevention. Internists work with their patients to identify the risk factors and promote healthy habits.
Posts and Affiliations
Clinical Director – Multidisciplinary Breast Unit Kliniken Essen-Mitte, Germany
Lead Breast Cancer Research Program, Kliniken Essen-Mitte
Executive Board Member of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)
Additional Roles
ESMO Faculty – Breast Cancer
Member of AWO Gyn – Commission for plastic and reconstructive surgery
Speaker of the AGIMed – Commission for Integrative Medicine of the AGO
Member of the Organ Commission Mamma of the AGO
Scientific Director of the WSG study group
Global PI, Head of clinical investigations and trials 27
IDMC´s, Steering Boards national and international
Scientific committee of international and national symposia in breast cancer and surgical oncology
Organization Memberships
Memberships: European Society of Medical Oncology, American Society of Clinical Oncology,
European Academy of Senology, German Cancer Society, German Society of Gynecology and
Obstetrics, Working Group for Gynecological Oncology, German Society of Senology,
Publications
Peer reviewed Publications: 322
First/Senior Author: 38
h-Index/i10-Index 66/232
Congress Abstracts/Proceedings: 443
Books/Book Chapter: 59
Invited oral Presentations/Lectures: 1032
Dr. Napassorn Khumchum is a board-certified physiatrist (Diplomate, Thai Board of Rehabilitation Medicine, 2024) at Chonburi Hospital. She provides care in modality, transcranial magnetic stimulation (TMS), and electromyography (EMG) clinics. Her expertise includes neurorehabilitation, stroke recovery, and geriatric rehabilitation. She treats chronic pain and performs ultrasound-guided procedures. She also offers robotic and wearable exoskeleton gait training.
She helps develop and apply advanced rehabilitation technologies. She also serves as a medical lecturer. Her research on the Ipswich Touch Test was presented at the Royal College of Physiatrists Conference 2024. It was published in The Foot (Vol. 61, Dec 2024). Her advanced training includes AOCNR 2023 and courses in spasticity, pain, and ultrasound-guided toxin injection.
Residency: Rehabilitation Medicine, Chulalongkorn University (2024). M.D., Thammasat University (2017). She was an invited speaker at Chonburi Cancer Hospital on swallowing rehabilitation in head and neck cancer patients.
Dr. Sirada Udombhakdibongse (Dr. Dream) is a physiatrist at Chiraprawat Fort Hospital, Nakorn Sawan. Her focus is geriatric and sports rehabilitation, ultrasound‑guided interventions, and chronic pain management. She completed a PM&R residency at Phramongkutklao Hospital (2021–2024). She earned her M.D. from Phramongkutklao College of Medicine (2012–2017).
Her work includes a 2024 study on the prevalence and associated factors of neck and shoulder pain in medical students at a Thai military school. She also conducted earlier studies on prevalence and quality‑of‑life outcomes in type 2 diabetes and childhood obesity.
She has advanced training in dry needling (TASP–TMS), MSK interventions (Vachira Phuket Hospital, 2025), sports rehabilitation, and ultrasound‑guided injections. She has also joined international programs (Atlantic Sport Health System, New Jersey, 2024; TOSSM 2025; AOCNR 2023).
Dr. Mustafa Emiroglu is a general surgery specialist at Memorial Bodrum Hospital. He has significant experience from his work at Sağlık Bilimleri University Tepecik SUAM (2016–2023) and Kırşehir Hospital (1997–1999).
He earned his medical degree from Istanbul University Cerrahpaşa Faculty of Medicine. He completed his specialization at Tepecik Training and Research Hospital. Dr. Emiroglu is a member of the Turkish Society of Surgery, the Endocrine Surgery Association, and the Colorectal Surgery Association.
He has attended advanced courses, including the Europe Senology Academia. He has also received training in proctologic, hemorrhoidal, and oncoplastic breast surgery, as well as thyroid diseases.
2002 – 2008 – Siriraj Medical School, Mahidol University
2008 – 2013 – Department of Internal Medicine, Rajavithi Hospital
2013 – 2015 – Department of Cardiology, Internal Medicine Rajavithi Hospital
2019 – 2020 – Cardiology Intervention, Department of Cardiology, Internal Medicine Rajavithi Hospital
Languages: English and Thai